Atul A Deodhar (Atul Deodhar, A Deodhar)

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 52

Top Topics

Disease Activity

Ankylosing Spondylitis

Top Venues

Annals of the rheumatic diseases

ACR open rheumatology

Clinical rheumatology

Rheumatology and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Sonam Kiwalkar, Richard A Howard, Dongseok Choi, Atul A Deodhar
A mixed methods study to uncover impediments to accurate diagnosis of nonradiographic axial spondyloarthritis in the USA. Clinical rheumatology (2023)
Désirée Mfm van der Heijde, Atul A Deodhar, Xenofon Baraliakos, Matthew A Brown, Hiroaki Dobashi, Maxime Dougados, Dirk Elewaut, Alicia M Ellis, Carmen Fleurinck, Karl Gaffney, Lianne S Gensler, Nigil Haroon, Marina Magrey, Walter P Maksymowych, Alexander Marten, Ute Massow, Marga Oortgiesen, Denis Poddubnyy, Martin Rudwaleit, Julie Shepherd-Smith, Tetsuya Tomita, Filip E Van den Bosch, Thomas Vaux, Huji Xu
Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trials. Annals of the rheumatic diseases (2023)
Xenofon Baraliakos, Atul A Deodhar, Désirée Mfm van der Heijde, Marina Magrey, Walter P Maksymowych, Tetsuya Tomita, Huji Xu, Ute Massow, Carmen Fleurinck, Alicia M Ellis, Thomas Vaux, Julie Shepherd-Smith, Alexander Marten, Lianne S Gensler
Bimekizumab treatment in patients with active axial spondyloarthritis: 52-week efficacy and safety from the randomised parallel phase 3 BE MOBILE 1 and BE MOBILE 2 studies. Annals of the rheumatic diseases (2023)
Holly L Rosenzweig, Emily E Vance, Kofi Asare-Konadu, Kylie V Koney, Ellen J Lee, Atul A Deodhar, Rouhin Sen, Liron Caplan, Ruth J Napier
Card9/neutrophil signalling axis promotes IL-17A-mediated ankylosing spondylitis. Annals of the rheumatic diseases (2023)
Atul A Deodhar, Denis Poddubnyy, Proton Rahman, Joerg Ermann, Tetsuya Tomita, Rebeca Bolce, Soyi Liu Leage, Andris Kronbergs, Caroline Johnson, Joana Araújo, Ann Leung, Désirée Mfm van der Heijde
Long-term Safety and Efficacy of Ixekizumab in Patients With Axial Spondyloarthritis: 3-year Data From the COAST Program. The Journal of rheumatology (2023)
Dennis McGonagle, Iain B McInnes, Atul A Deodhar, Larissa Valor-Méndez, May Shawi, Soumya D Chakravarty, Alexa P Kollmeier, Xie L Xu, Shihong Sheng, Stephen Xu, Christopher T Ritchlin, Proton Rahman, Phillip J Mease
Guselkumab, a Selective Interleukin-23 p19 Subunit Inhibitor, Resolves Dactylitis in Patients With Active Psoriatic Arthritis: Pooled Results Through Week 52 From Two Phase 3 Studies. ACR open rheumatology (2023)
Victoria Navarro-Compán, Xenofon Baraliakos, Marina N Magrey, Andrew Östör, Christopher D Saffore, Manish Mittal, In-Ho Song, Fabiana Ganz, Jayne Stigler, Atul A Deodhar
Effect of Upadacitinib on Disease Activity, Pain, Fatigue, Function, Health-Related Quality of Life and Work Productivity for Biologic Refractory Ankylosing Spondylitis. Rheumatology and therapy (2023)
Christopher T Ritchlin, Atul A Deodhar, Wolf-Henning Boehncke, Enrique Roberto Soriano, Alexa P Kollmeier, Xie L Xu, Federico Zazzetti, May Shawi, Yusang Jiang, Shihong Sheng, Philip S Helliwell
Multidomain Efficacy and Safety of Guselkumab Through 1 Year in Patients With Active Psoriatic Arthritis With and Without Prior Tumor Necrosis Factor Inhibitor Experience: Analysis of the Phase 3, Randomized, Placebo-Controlled DISCOVER-1 Study. ACR open rheumatology 5 (3) (2023)
Victoria Navarro-Compán, Xenofon Baraliakos, Marina N Magrey, Andrew Östör, Christopher D Saffore, Manish Mittal, In-Ho Song, Fabiana Ganz, Jayne Stigler, Atul A Deodhar
Effect of Upadacitinib on Disease Activity, Pain, Fatigue, Function, Health-Related Quality of Life and Work Productivity for Biologic Refractory Ankylosing Spondylitis. Rheumatology and therapy (2023)
Atul A Deodhar, Natalie J Shiff, Cinty Gong, Eric K H Chan, Elizabeth C Hsia, Kim Hung Lo, Alianu Akawung, Lilianne Kim, Stephen Xu, John D Reveille
Effect of Intravenous Golimumab on Fatigue and the Relationship with Clinical Response in Adults with Active Ankylosing Spondylitis in the Phase 3 GO-ALIVE Study. Rheumatology and therapy (2023)
Désirée Mfm van der Heijde, Atul A Deodhar, Xenofon Baraliakos, Matthew A Brown, Hiroaki Dobashi, Maxime Dougados, Dirk Elewaut, Alicia M Ellis, Carmen Fleurinck, Karl Gaffney, Lianne S Gensler, Nigil Haroon, Marina Magrey, Walter P Maksymowych, Alexander Marten, Ute Massow, Marga Oortgiesen, Denis Poddubnyy, Martin Rudwaleit, Julie Shepherd-Smith, Tetsuya Tomita, Filip E Van den Bosch, Thomas Vaux, Huji Xu
Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trials. Annals of the rheumatic diseases (2023)
Christopher T Ritchlin, Atul A Deodhar, Wolf-Henning Boehncke, Enrique Roberto Soriano, Alexa P Kollmeier, Xie L Xu, Federico Zazzetti, May Shawi, Yusang Jiang, Shihong Sheng, Philip S Helliwell
Multidomain Efficacy and Safety of Guselkumab Through 1 Year in Patients With Active Psoriatic Arthritis With and Without Prior Tumor Necrosis Factor Inhibitor Experience: Analysis of the Phase 3, Randomized, Placebo-Controlled DISCOVER-1 Study. ACR open rheumatology (2023)
Christopher T Ritchlin, Atul A Deodhar, Wolf-Henning Boehncke, Enrique Roberto Soriano, Alexa P Kollmeier, Xie L Xu, Federico Zazzetti, May Shawi, Yusang Jiang, Shihong Sheng, Philip S Helliwell
Multidomain Efficacy and Safety of Guselkumab Through 1 Year in Patients With Active Psoriatic Arthritis With and Without Prior Tumor Necrosis Factor Inhibitor Experience: Analysis of the Phase 3, Randomized, Placebo-Controlled DISCOVER-1 Study. ACR open rheumatology 5 (3) (2023)
Christopher T Ritchlin, Atul A Deodhar, Wolf-Henning Boehncke, Enrique Roberto Soriano, Alexa P Kollmeier, Xie L Xu, Federico Zazzetti, May Shawi, Yusang Jiang, Shihong Sheng, Philip S Helliwell
Multidomain Efficacy and Safety of Guselkumab Through 1 Year in Patients With Active Psoriatic Arthritis With and Without Prior Tumor Necrosis Factor Inhibitor Experience: Analysis of the Phase 3, Randomized, Placebo-Controlled DISCOVER-1 Study. ACR open rheumatology 5 (3) (2023)
Atul A Deodhar, Helena Marzo-Ortega, Joseph Wu, Cunshan Wang, Oluwaseyi Dina, Keith S Kanik, Lara Fallon, Lianne S Gensler
Tofacitinib Efficacy and Safety in Patients With Ankylosing Spondylitis by Prior Biologic Disease-Modifying Antirheumatic Drug Use: A Post Hoc Analysis. ACR open rheumatology (2023)
Laura C Coates, Atul A Deodhar
Is Axial Psoriatic Arthritis the Same as Ankylosing Spondylitis With Psoriasis: A Debate. The Journal of rheumatology (2023)
Beverly Cheok Kuan Ng, Deepak R Jadon, Adewale O Adebajo, Gizem Ayan, Kristina Callis Duffin, Vinod Chandran, Laura C Coates, Maria Antonietta D'Agostino, Kurt de Vlam, Atul A Deodhar, Lihi Eder, Amit Garg, Dafna D Gladman, Niti Goel, Alice B Gottlieb, M Elaine Husni, Arnon M Katz, Arthur Kavanaugh, Ennio Lubrano, Phillip J Mease, Joseph Frank Merola, Peter Nash, Philip S Helliwell, Stephen R Pennington, Lourdes Maria Perez-Chada, Fabian Proft, Cheryl F Rosen, Laura Savage, Cláudia Goldenstein-Schainberg, Stefan Siebert, Enrique Roberto Soriano, Ingrid Steinkoenig, William Tillett, April W Armstrong, Oliver M FitzGerald
Proceedings of the GRAPPA 2022 Executive Retreat. The Journal of rheumatology (2023)
Atul A Deodhar, Tejpal Gill, Marina N Magrey
Human Leukocyte Antigen B27-Negative Axial Spondyloarthritis: What Do We Know? ACR open rheumatology (2023)
Marina N Magrey, James Cheng-Chung Wei, Arne Yndestad, Andrew G Bushmakin, Joseph C Cappelleri, Oluwaseyi Dina, Atul A Deodhar
Relationships of Work Productivity and Activity Impairment with Patient-Reported Outcomes in Ankylosing Spondylitis: Results from Two Trials. Arthritis care & research (2023)
Dafna D Gladman, Phillip J Mease, Paul Bird, Enrique Roberto Soriano, Soumya D Chakravarty, May Shawi, Frederic Lavie, Cinty Gong, Evan Leibowitz, Denis Poddubnyy, Lai Shan Tam, Philip S Helliwell, Arthur Kavanaugh, Atul A Deodhar, Mikkel Østergaard, Xenofon Baraliakos
Correspondence on 'No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post-hoc analyses of psoriatic arthritis-related 'physician-reported spondylitis'?' by Braun and Landewé. Annals of the rheumatic diseases (2022)
Désirée Mfm van der Heijde, Lianne S Gensler, Walter P Maksymowych, Robert B M Landewé, Martin Rudwaleit, Lars Bauer, Thomas Kumke, Mindy Kim, Simone Emanuele Auteri, Bengt Hoepken, Atul A Deodhar
Long-term safety and clinical outcomes of certolizumab pegol treatment in patients with active non-radiographic axial spondyloarthritis: 3-year results from the phase 3 C-axSpAnd study. RMD open 8 (1) (2022)
Laura C Coates, Philip Mease, Andris Kronbergs, Cameron Helt, David Sandoval, So Young Park, Bernard Combe, Peter Nash, Atul A Deodhar
Efficacy and safety of ixekizumab in patients with active psoriatic arthritis with and without concomitant conventional disease-modifying antirheumatic drugs: SPIRIT-P1 and SPIRIT-P2 3-year results. Clinical rheumatology 41 (10) (2022)
M Elaine Husni, Atul A Deodhar, Sergio Schwartzman, Soumya D Chakravarty, Elizabeth C Hsia, Jocelyn H Leu, Yiying Zhou, Kim H Lo, Arthur Kavanaugh
Pooled safety results across phase 3 randomized trials of intravenous golimumab in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. Arthritis research & therapy 24 (1) (2022)
Xenofon Baraliakos, Atul A Deodhar, Maxime Dougados, Lianne S Gensler, Anna Molto, Josef S Smolen, Alan J Kivitz, Denis Poddubnyy, Marga Oortgiesen, Thomas Vaux, Carmen Fleurinck, Julie Shepherd-Smith, Christine de la Loge, Natasha de Peyrecave, Désirée van der Heijde
Safety and Efficacy of Bimekizumab in Patients With Active Ankylosing Spondylitis: Three-Year Results From a Phase IIb Randomized Controlled Trial and Its Open-Label Extension Study. Arthritis & rheumatology (Hoboken, N.J.) (2022)
Phillip J Mease, Atul A Deodhar
Differentiating nonradiographic axial spondyloarthritis from its mimics: a narrative review. BMC musculoskeletal disorders 23 (1) (2022)
Philip C Robinson, Pedro M Machado, Nigil Haroon, Lianne S Gensler, John D Reveille, Vanessa Taieb, Thomas Vaux, Carmen Fleurinck, Marga Oortgiesen, Natasha de Peyrecave, Atul A Deodhar
Minimal Impact of the COVID-19 Pandemic on Disease Activity and Health-Related Quality of Life in Patients With Ankylosing Spondylitis Receiving Bimekizumab: Exploratory Analyses From a Phase 2b Open-Label Extension Study. ACR open rheumatology 4 (9) (2022)
Phillip J Mease, Atul A Deodhar, Désirée Mfm van der Heijde, Frank Behrens, Alan J Kivitz, Jeffrey Neal, Jonghyeon Kim, Shalabh Singhal, Miroslawa Nowak, Subhashis Banerjee
Efficacy and safety of selective TYK2 inhibitor, deucravacitinib, in a phase II trial in psoriatic arthritis. Annals of the rheumatic diseases 81 (6) (2022)
Désirée Mfm van der Heijde, Xenofon Baraliakos, Joachim Sieper, Atul A Deodhar, Robert D Inman, Hideto Kameda, Xiaofeng Zeng, Yunxia Sui, Xianwei Bu, Aileen L Pangan, Peter Wung, In-Ho Song
Efficacy and safety of upadacitinib for active ankylosing spondylitis refractory to biological therapy: a double-blind, randomised, placebo-controlled phase 3 trial. Annals of the rheumatic diseases 81 (11) (2022)
Philip C Robinson, Walter P Maksymowych, Lianne S Gensler, Stephen Hall, Martin Rudwaleit, Bengt Hoepken, Lars Bauer, Thomas Kumke, Mindy Kim, Natasha de Peyrecave, Atul A Deodhar
Certolizumab Pegol Efficacy in Patients With Non-Radiographic Axial Spondyloarthritis Stratified by Baseline MRI and C-Reactive Protein Status: An Analysis From the C-axSpAnd Study. ACR open rheumatology 4 (9) (2022)
Atul A Deodhar, Suleman Bhana, Kevin Winthrop, Lianne S Gensler
COVID-19 Outcomes and Vaccination in Patients with Spondyloarthritis. Rheumatology and therapy 9 (4) (2022)
Atul A Deodhar, Bernard Combe, Ana P Accioly, Rebecca Bolce, Danting Zhu, Amanda M Gellett, Aubrey Trevelin Sprabery, Gerd-Rüdiger R Burmester
Safety of ixekizumab in patients with psoriatic arthritis: data from four clinical trials with over 2000 patient-years of exposure. Annals of the rheumatic diseases 81 (7) (2022)
Abhijeet Danve, Atul A Deodhar
Treatment of axial spondyloarthritis: an update. Nature reviews. Rheumatology 18 (4) (2022)
Francisco Airton Castro Rocha, Atul A Deodhar
Rebuttal letter on "Comment on Tumor necrosis factor inhibitors prevent structural damage in hips in ankylosing spondylitis-time to reconsider treatment guidelines? A case series and review of literature". Clinical rheumatology 40 (5) (2021)
Atul A Deodhar, Désirée van der Heijde, Joachim Sieper, Filip Van den Bosch, Walter P Maksymowych, Tae Hwan Kim, Kishimoto Mitsumasa, Andrew Ostor, Bernard Combe, Yunxia Sui, Alvina D Chu, In-Ho Song
Safety and Efficacy of Upadacitinib in Patients With Active Ankylosing Spondylitis and an Inadequate Response to Nonsteroidal Antiinflammatory Drug Therapy: One-Year Results of a Double-Blind, Placebo-Controlled Study and Open-Label Extension. Arthritis & rheumatology (Hoboken, N.J.) (2021)
Atul A Deodhar, Paula Sliwinska-Stanczyk, Huji Xu, Xenofon Baraliakos, Lianne S Gensler, Dona Fleishaker, Lisy Wang, Joseph Wu, Sujatha Menon, Cunshan Wang, Oluwaseyi Dina, Lara Fallon, Keith S Kanik, Désirée Mfm van der Heijde
Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study. Annals of the rheumatic diseases (2021)
Jeffrey R Curtis, Kevin Winthrop, Rhonda L Bohn, Robert Suruki, Sarah Siegel, Jeffrey L Stark, Fenglong Xie, Huifeng Yun, Lang Chen, Atul A Deodhar
The Annual Diagnostic Prevalence of Ankylosing Spondylitis and Axial Spondyloarthritis in the United States Using Medicare and MarketScan Databases. ACR open rheumatology 3 (11) (2021)
Jeffrey R Curtis, Stacey S Cofield, S Louis Bridges, John R Bassler, Atul A Deodhar, Theresa L Ford, Joseph Huffstutter, Allen Jankeel, Alan Kivitz, Shaila Kamal, Stephen Lindsey, Ilhem Messaoudi, Norma Mendoza, Kaleb D Michaud, Ted R Mikuls, David Ridley, William Shergy, Sarah A R Siegel, Kevin L Winthrop
The Safety and Immunologic Effectiveness of the Live Varicella-Zoster Vaccine in Patients Receiving Tumor Necrosis Factor Inhibitor Therapy : A Randomized Controlled Trial. Annals of internal medicine 174 (11) (2021)
Atul A Deodhar, S D Chakravarty, C Cameron, S Peterson, R Hensman, S Fogarty, P Spin, S Kafka, S Nair, L S Gensler
A systematic review and network meta-analysis of current and investigational treatments for active ankylosing spondylitis. Clinical rheumatology 39 (8) (2020)
Atul A Deodhar, Corine Miceli-Richard, Xenofon Baraliakos, Helena Marzo-Ortega, Dafna D Gladman, Ricardo Blanco, Ayan Das Gupta, Ruvie Martin, Jorge Safi, Brian Porter, Abhijit Shete, James Todd Rosenbaum
Incidence of Uveitis in Secukinumab-treated Patients With Ankylosing Spondylitis: Pooled Data Analysis From Three Phase 3 Studies. ACR open rheumatology 2 (5) (2020)
Francisco Airton Castro Rocha, Ana Carolina Matias Dinelly Pinto, Jailson Rodrigues Lopes, Atul A Deodhar
Tumor necrosis factor inhibitors prevent structural damage in hips in ankylosing spondylitis-time to reconsider treatment guidelines? A case series and review of literature. Clinical rheumatology 40 (5) (2020)
Tore K Kvien, Philip Gerard Conaghan, Laure Gossec, Vibeke Strand, Mikkel Østergaard, Denis Poddubnyy, Nicole Williams, Brian Porter, Abhijit Shete, Isabelle Gilloteau, Atul A Deodhar
Secukinumab Provides Sustained Reduction in Fatigue in Patients with Ankylosing Spondylitis: Long-term Results of Two Phase III Randomized Controlled Trials. Arthritis care & research (2020)
Atul A Deodhar, Philip Mease, Proton Rahman, Victoria Navarro-Compán, Helena Marzo-Ortega, Theresa Hunter, David Sandoval, Andris Kronbergs, Luis Leon, Mingyang Shan, Ann Leung, Kurt De Vlam, Vibeke Strand
Ixekizumab Improves Patient-Reported Outcomes in Non-Radiographic Axial Spondyloarthritis: Results from the Coast-X Trial. Rheumatology and therapy 8 (1) (2020)
Atul A Deodhar, Ricardo Blanco, Eva Dokoupilová, Stephen Hall, Hideto Kameda, Alan J Kivitz, Denis Poddubnyy, Marleen van de Sande, Anna S Wiksten, Brian O Porter, Hanno B Richards, Sibylle Haemmerle, Jürgen Braun
Improvement of Signs and Symptoms of Nonradiographic Axial Spondyloarthritis in Patients Treated With Secukinumab: Primary Results of a Randomized, Placebo-Controlled Phase III Study. Arthritis & rheumatology (Hoboken, N.J.) 73 (1) (2020)
Abhijeet Danve, Atul A Deodhar
Rebuttal letter to Dr. Fallahi's letter about our manuscript "Axial spondyloarthritis in the USA: diagnostic challenges and missed opportunities." Clin Rheumatol. 2018 Dec 26. https://doi.org/10.1007/s10067-018-4397-3. Clinical rheumatology 38 (5) (2019)
Stefan Schreiber, Jean-Frederic Colombel, Brian G Feagan, Kristian Reich, Atul A Deodhar, Iain B McInnes, Brian Porter, Ayan Das Gupta, Luminita Pricop, Todd Fox
Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective analysis of pooled data from 21 clinical trials. Annals of the rheumatic diseases 78 (4) (2019)
Abhijeet Danve, Atul A Deodhar
Axial spondyloarthritis in the USA: diagnostic challenges and missed opportunities. Clinical rheumatology 38 (3) (2018)
Daniel M Hartung, Kirbee Johnston, David M Cohen, Thuan Nguyen, Atul A Deodhar, Dennis N Bourdette
Elephant in the room. Annals of the rheumatic diseases 78 (2) (2018)
Désirée Mfm van der Heijde, Atul A Deodhar, James C Wei, Edit Drescher, Dona Fleishaker, Thijs Hendrikx, David Li, Sujatha Menon, Keith S Kanik
Tofacitinib in patients with ankylosing spondylitis: a phase II, 16-week, randomised, placebo-controlled, dose-ranging study. Annals of the rheumatic diseases 76 (8) (2017)
Jürgen Braun, Xenofon Baraliakos, Atul A Deodhar, Dominique Baeten, Joachim Sieper, Paul Emery, Aimee Readie, Ruvie Martin, Shephard Mpofu, Hanno B Richards, null null
Effect of secukinumab on clinical and radiographic outcomes in ankylosing spondylitis: 2-year results from the randomised phase III MEASURE 1 study. Annals of the rheumatic diseases 76 (6) (2016)
Charles Peterfy, Vibeke Strand, Lu Tian, Mikkel Østergaard, Ying Lu, Julie DiCarlo, Peter Countryman, Atul A Deodhar, Robert Landewé, Veena K Ranganath, Orrin Troum, Philip G Conaghan
Short-term changes on MRI predict long-term changes on radiography in rheumatoid arthritis: an analysis by an OMERACT Task Force of pooled data from four randomised controlled trials. Annals of the rheumatic diseases 76 (6) (2016)
Atul A Deodhar, Vibeke Strand, Jonathan Kay, Juergen Braun
The term 'non-radiographic axial spondyloarthritis' is much more important to classify than to diagnose patients with axial spondyloarthritis. Annals of the rheumatic diseases 75 (5) (2016)
Joachim Sieper, Atul A Deodhar, Helena Marzo-Ortega, Jacob A Aelion, Ricardo Blanco, Tseng Jui-Cheng, Mats Andersson, Brian Porter, Hanno B Richards, null null
Secukinumab efficacy in anti-TNF-naive and anti-TNF-experienced subjects with active ankylosing spondylitis: results from the MEASURE 2 Study. Annals of the rheumatic diseases 76 (3) (2016)